Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Apogee Therapeutics Inc (APGE)

Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,449,014
  • Shares Outstanding, K 69,485
  • Annual Sales, $ 0 K
  • Annual Income, $ -255,840 K
  • EBIT $ -286 M
  • EBITDA $ -292 M
  • 60-Month Beta 1.39
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.94

Options Overview Details

View History
  • Implied Volatility 60.48% (+2.41%)
  • Historical Volatility 70.89%
  • IV Percentile 25%
  • IV Rank 5.87%
  • IV High 236.20% on 06/20/25
  • IV Low 49.53% on 12/10/25
  • Expected Move (DTE 20) 5.95 (7.65%)
  • Put/Call Vol Ratio 0.37
  • Today's Volume 89
  • Volume Avg (30-Day) 706
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 13,935
  • Open Int (30-Day) 14,700
  • Expected Range 71.87 to 83.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -1.12
  • Number of Estimates 4
  • High Estimate -1.05
  • Low Estimate -1.22
  • Prior Year -0.95
  • Growth Rate Est. (year over year) -17.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.22 +19.32%
on 03/20/26
85.04 -8.49%
on 03/25/26
+7.82 (+11.17%)
since 02/27/26
3-Month
60.35 +28.95%
on 02/09/26
85.04 -8.49%
on 03/25/26
+0.50 (+0.65%)
since 12/26/25
52-Week
26.20 +197.02%
on 04/08/25
85.04 -8.49%
on 03/25/26
+38.57 (+98.27%)
since 03/27/25

Most Recent Stories

More News
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million

SAN FRANCISCO and BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for...

APGE : 77.82 (-0.77%)
Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering

SAN FRANCISCO and BOSTON, March 24, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for...

APGE : 77.82 (-0.77%)
Stocks Sharply Higher as President Trump Seeks to End Iran War

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.15%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.22%. June E-mini S&P...

ALK : 36.16 (-7.16%)
GOOGL : 274.34 (-2.34%)
AAPL : 248.80 (-1.62%)
TRI : 89.43 (-1.05%)
TSLA : 361.83 (-2.76%)
VVV : 33.42 (-3.55%)
SPY : 634.09 (-1.71%)
INSM : 145.30 (-1.56%)
DKNG : 20.72 (-2.59%)
META : 525.72 (-3.99%)
EL : 67.23 (-3.61%)
AAL : 10.30 (-3.83%)
Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering

SAN FRANCISCO and BOSTON, March 23, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for...

APGE : 77.82 (-0.77%)
Stocks Rally as President Trump Eases Iran Threats

The S&P 500 Index ($SPX ) (SPY ) today is up +2.10%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +2.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.19%. June E-mini S&P futures (ESM26...

ALK : 36.16 (-7.16%)
GOOGL : 274.34 (-2.34%)
AAPL : 248.80 (-1.62%)
ADI : 307.44 (-1.91%)
TRI : 89.43 (-1.05%)
TSLA : 361.83 (-2.76%)
WDC : 275.34 (+0.73%)
VVV : 33.42 (-3.55%)
AMD : 201.99 (-0.87%)
SPY : 634.09 (-1.71%)
INSM : 145.30 (-1.56%)
DKNG : 20.72 (-2.59%)
Stocks Rebound as Crude Oil Sinks After President Trump Eases Iran Threats

The S&P 500 Index ($SPX ) (SPY ) today is up +1.73%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.97%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.79%. June E-mini S&P futures (ESM26...

ALK : 36.16 (-7.16%)
GOOGL : 274.34 (-2.34%)
UAL : 88.44 (-4.59%)
AAPL : 248.80 (-1.62%)
DHI : 134.19 (-1.30%)
BLDR : 80.43 (-2.12%)
$IUXX : 23,132.77 (-1.93%)
ZNM26 : 110-050s (-0.01%)
MSFT : 356.77 (-2.51%)
KBH : 50.91 (-1.93%)
TSLA : 361.83 (-2.76%)
APGE : 77.82 (-0.77%)
Apogee Therapeutics Announces Positive Phase 2 Part A 52-Week Data of Zumilokibart (APG777), Demonstrating Maintenance and Deepening of Responses with Every 3- and 6-Month Dosing in Moderate-to-Severe Atopic Dermatitis

APEX Part A data demonstrated durable maintenance of response at 52-weeks for every 3- and 6-months dosing, respectively, including: - 75% and 85% patients maintained EASI-75 - 86% and 78% patients...

APGE : 77.82 (-0.77%)
Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026

SAN FRANCISCO and BOSTON, March 22, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class...

APGE : 77.82 (-0.77%)
Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results

Zumilokibart (APG777) trials continue to advance in atopic dermatitis (AD) with plans for expansion indications underway: - APEX Phase 2 Part A 52-week data expected this month - APEX Phase 2 Part...

APGE : 77.82 (-0.77%)
Apogee Therapeutics to Participate in Upcoming March Conferences

SAN FRANCISCO and BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the TD Cowen 46th...

APGE : 77.82 (-0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Apogee Therapeutics LLC is a biotechnology company advancing novel, potentially therapies to address the needs of the millions of people living with immunological and inflammatory disorders. Apogee Therapeutics LLC is based in SAN FRANCISCO.

See More

Key Turning Points

3rd Resistance Point 83.90
2nd Resistance Point 82.07
1st Resistance Point 79.95
Last Price 77.82
1st Support Level 75.99
2nd Support Level 74.16
3rd Support Level 72.04

See More

52-Week High 85.04
Last Price 77.82
Fibonacci 61.8% 62.56
Fibonacci 50% 55.62
Fibonacci 38.2% 48.68
52-Week Low 26.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.